Professor Pavel Jansa
First Faculty of Medicine and General Teaching Hospital, Prague (Czechia)
Macitentan tadalafil Fixed Dose Combination (FDC) in treatment-naive and prior monotherapy patients with Pulmonary Arterial Hypertension (PAH): insights from A DUE
Event: ESC Congress 2023
Topic: Pulmonary Hypertension
Session: Current treatment of pulmonary hypertension: it is all about vasodilators
Q&A/discussion and meeting close - Optimizing patient care: a state-of-the-art update on pulmonary hypertension management.
Event: ESC Congress 2016
Topic: Chronic pulmonary hypertension
Session: Optimizing patient care: a state-of-the-art update on pulmonary hypertension management
PAH: defining the current clinical challenges.
Event: ESC Congress 2016
Topic: Chronic pulmonary hypertension
Session: Optimizing patient care: a state-of-the-art update on pulmonary hypertension management
ESC 365 is supported by
